GM-CSF was initially characterized as a factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. It is also a growth factor for erythroid, megakaryocyte, and eosinophil progenitors. GM-CSF is produced by T cells, B cells, macrophages, mast cells, endothelial cells, fibroblasts, and adipocytes in response to cytokine or inflammatory stimuli. On mature hematopoietic cells, GM-CSF acts as a prosurvival factor and activates effector functions of granulocytes, monocytes/macrophages, and eosinophils. It promotes a Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity. The 22 kDa glycosylated GM-CSF, similar to IL-3 and IL-5, is a cytokine with a core of four bundled α-helices. Mature mouse GM-CSF shares 49% - 54% amino acid sequence identity with canine, feline, human, and porcine GM-CSF and 69% with rat GM-CSF. The activity of GM-CSF is species specific between human and mouse. Mouse GM-CSF is only weakly active on rat cells, although rat GM-CSF is fully active on mouse cells.
GM-CSF最初被鉴定为一种能够在体外支持粒细胞-巨噬细胞祖细胞集落形成的因子。同时,它也是红系细胞、巨核细胞及嗜酸性粒细胞祖细胞的生长因子。GM-CSF可由T细胞、B细胞、巨噬细胞、肥大细胞、内皮细胞、成纤维细胞及脂肪细胞在细胞因子或炎症刺激下产生。
在成熟造血细胞中,GM-CSF作为一种促存活因子,能够激活粒细胞、单核/巨噬细胞及嗜酸性粒细胞的效应功能。它还可促进偏向Th1型的免疫反应、血管生成、过敏性炎症以及自身免疫反应的发生。分子量约为22 kDa的糖基化GM-CSF与IL-3和IL-5类似,属于具有四个束状α螺旋核心结构的细胞因子。
成熟小鼠GM-CSF与犬、猫、人及猪来源的GM-CSF在氨基酸序列上具有约49%–54%的同源性,与大鼠GM-CSF具有约69%的同源性。GM-CSF的活性具有物种特异性:小鼠GM-CSF对大鼠细胞仅表现出较弱活性,而大鼠GM-CSF对小鼠细胞则具有完全活性。
| 目录编号 | 122-03 |
|---|---|
| 制造国家 | 美国 |
| 产品编码 | rmGM-CSF |
| 规格/数量 | 5 µg, 20 µg and 1 mg |
| 产品用途 | 本产品仅供研究使用。未经批准,不得用于人体、动物或体外诊断程序。 |
| 储存 | 收到后,请储存于 -20°C。复溶后,可在 2-8°C 保存最多一周。为获得最大稳定性,请分装并储存于 -20°C。避免反复冻融。 |
| 运输 | 干冰。 |
| Synonyms | CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin, Sargramostim |
| AA Sequence | APTRSPITVTRPWKHVEAIKEALNLLDDMPVTLNEEVEVVSNEF SFKKLTCVQTRLKIFEQGLRGNFTKLKGALNMTASYYQTYCPP TPETDCETQVTTYADFIDSLKTFLTDIPFECKKPGQKAAAHHHHHH |
| Source | Yeast |
| Molecular Weight | Predicted molecular weight at 15.1 kDa. Apparent molecular weight on SDS-PAGE at approximately 17 & 21 kDa due to glycosylation. |
| Purity | > 95% by SDS-PAGE |
| Physical Appearance | White lyophilized powder. |
| Formulation | Lyophilized from a 0.2μm filtered solution in PBS, pH 7.4. |
| Endotoxin | <0.1 ng/μg of protein (<1 EU/μg) |
| Reconstitution | Reconstitute in sterile distilled water containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. |